180 related articles for article (PubMed ID: 2511920)
1. Gastric pH and endoscopic appearance after Algicon administration.
Lambert JR; Korman MG; Nicholson L
Br J Clin Pract Suppl; 1989 Feb; 66():25-8; discussion 35-6. PubMed ID: 2511920
[No Abstract] [Full Text] [Related]
2. Comparative intragastric pH profile of Algicon versus Gaviscon.
Stoddard CJ; Morgan GE
Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
[No Abstract] [Full Text] [Related]
3. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
Vatier J; Vitre MT; Vallot T; Mignon M
Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
[TBL] [Abstract][Full Text] [Related]
4. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
5. [In vitro studies of antacids. I].
Schnekenburger J
Arzneimittelforschung; 1974 Feb; 24(2):142-4. PubMed ID: 4406362
[No Abstract] [Full Text] [Related]
6. [Bioavailability of orally administered iron. Effects of alginate/antacid administration].
Campo S; Breda E
Minerva Med; 1992 Mar; 83(3):145-7. PubMed ID: 1553063
[TBL] [Abstract][Full Text] [Related]
7. Algicon in the management of gastro-oesophageal reflux.
Lambert JR; Korman MG; Nicholson L
Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
[No Abstract] [Full Text] [Related]
8. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
Ward AE
Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
[No Abstract] [Full Text] [Related]
9. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
[TBL] [Abstract][Full Text] [Related]
10. [Steady intragastral pH measurement after application of antacid drugs (author's transl)].
Sommer H; Kasper H; Herzberger U
Med Klin; 1973 Nov; 68(46):1500-3. PubMed ID: 4782868
[No Abstract] [Full Text] [Related]
11. Gastro-oesophageal pH measurements during reflux induced by provocative tests.
Baldi F; Longanesi A; Ferrarini F; Ragazzini M; Michieletti G
Br J Clin Pract Suppl; 1989 Feb; 66():10-4; discussion 35-6. PubMed ID: 2511916
[No Abstract] [Full Text] [Related]
12. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
Mandel KG; Daggy BP; Brodie DA; Jacoby HI
Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
[TBL] [Abstract][Full Text] [Related]
13. The effect of sodium bicarbonate versus aluminum-magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients.
Simmons TC; Hogan DL; Selling JA; Maxwell V; Isenberg JI
J Clin Gastroenterol; 1986 Apr; 8(2):146-9. PubMed ID: 3018068
[TBL] [Abstract][Full Text] [Related]
14. In-vivo anti-reflux and raft properties of alginates.
Lambert JR; Korman MG; Nicholson L; Chan JG
Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
[TBL] [Abstract][Full Text] [Related]
15. Effect of a new antacid on basal and meal-stimulated gastric secretion.
Sun DC; Rider JA
Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):283-8. PubMed ID: 27093
[TBL] [Abstract][Full Text] [Related]
16. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
Washington N; Greaves JL; Iftikhar SY
Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
[TBL] [Abstract][Full Text] [Related]
17. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
18. Oesophagitis and the role of antacid therapy.
Rhodes J
Scand J Gastroenterol Suppl; 1982; 75():74-6. PubMed ID: 6959253
[No Abstract] [Full Text] [Related]
19. [Determination of neutralization capacity of antacids in gastric juice].
Halter F
Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
[TBL] [Abstract][Full Text] [Related]
20. [Testing of a new antacid with the Heidelberger capsule in healthy persons (author's transl)].
Aenishänslin HW; Stalder GA
Schweiz Rundsch Med Prax; 1975 Jul; 64(26):843-6. PubMed ID: 238192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
